SuperGen Selected to be Included in NASDAQ Biotechnology Index
November 17 2003 - 8:30AM
PR Newswire (US)
SuperGen Selected to be Included in NASDAQ Biotechnology Index
DUBLIN, Calif., Nov. 17 /PRNewswire-FirstCall/ -- SuperGen, Inc.
announced today that it will be included in the NASDAQ
Biotechnology Index, effective at the opening of the stock market
on November 24, 2003. All securities in the Biotechnology Index are
classified as either 'biotechnology' or 'pharmaceutical' according
to the FTSE Global Classification System(TM). In addition, each
security must be listed on the NASDAQ National Market and meet
requirements for market value, average daily share volume and
seasoning as a public company. Companies are added to or removed
from the Index on a semi-annual basis in May and November. Based in
Dublin, California, SuperGen is a pharmaceutical company dedicated
to the acquisition, rapid development and commercialization of
anticancer products. The Company's website can be reached at
http://www.supergen.com/. Contact: Tim Enns, Vice President,
Investor Relations & Business Development, SuperGen Inc.,
800-353-1075, ext. 111 DATASOURCE: SuperGen, Inc. CONTACT: Tim
Enns, Vice President, Investor Relations & Business
Development, SuperGen Inc., +1-800-353-1075, ext. 111 Web site:
http://www.supergen.com/
Copyright